|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Anti-infammatory and immuno- modulatory potential of the novel PDE4 inhibitor roflumilast in vitro显示文摘 | HATZELMANN A SCHUDT C | 2001 | J Pharmacol Exp Ther2001，297，1： | 1 |
| 2 | Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro显示文摘 | Hatzelmann A Schudt C | 2001 | J Pharmacol Exp Ther2001，297，1： | 1 |
| 3 | The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease 显示文摘 | Hatzelmann A Morcillo E Lungarell G | 2010 | Pulm Pharm Ther2010，23，4： | 1 |
| 4 | The preelinical pharmacology of roflumilast - a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease 显示文摘 | Hatzelmann A Moreillo E J Lungarella G | 2010 | Pulm PharmaeolTher2010，23，4： | 1 |
| 5 | Antipyretic effect of central apelinl3 on LPS-induced fever in the rat 显示文摘 | Hatzelmann T Harden LM Roth J | 2013 | Regul Pcpt2013，184，： | 1 |
| 6 | The preclinical pharmacology of roflumilast a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease 显示文摘 | Hatzelmann A Morcillo EJ Lungarella G | 2010 | Pulm Pharmacol Ther2010，23，4： | 1 |
| 7 | Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro 显示文摘 | HATZELMANN A SCHUDT C | 2001 | J Pharmacol Exp Ther2001，297，1： | 1 |
| 8 | Antiinammatory and immunomodulatory potential of the novel PDE4 inhibitor roumilast in vitro显示文摘 | Hatzelmann A Schudt C | 2001 | J Pharmacol Exp Ther2001，297，： | 1 |
| 9 | The preclinical pharmacology of roflumilast-a selective,oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease显示文摘 | Hatzelmann A Morcillo EJ Lungarella G | 2010 | Pulm Pharmacol Ther2010，23，4： | 1 |
| 10 | Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages显示文摘 | Tenor H Hatzelmann A Kupferschmidt R | 1995 | Clin Exp Allergy1995，25，： | 1 |
| 11 | Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects显示文摘 | Tenor H Hatzelmann A Church M K | 1996 | Br J Pharmacol1996，118，： | 1 |
| 12 | The preclinical pharmacology of roflumilast -a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease显示文摘 | HATZELMANN A MORCILLO E J LUNGARELLAG | 2010 | Pulm Pharmacol Ther2010，23，4： | 1 |
| 13 | The preclinical pharmacology of roflumilast-a selective,oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease显示文摘 | Hatzelmann A Morcillo EJ Lungarella G | 2010 | Pulm Pharmacol Ther2010，23，1： | 1 |
| 14 | Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro显示文摘 | Hatzelmann A Schudt C | 2001 | J Pharmacol Exp Ther2001，297，1： | 1 |
| 15 | Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects显示文摘 | Tenor H Hatzelmann A Church MK | 1996 | Br J Pharmacol1996，118，： | 1 |
| 16 | The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-in- duced proliferation and myofibroblast conversion 显示文摘 | Selige J Hatzelmann A Dunkem T | 2011 | J Cell Physiol2011，226，8： | 1 |
| 17 | Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects显示文摘 | Tenor H Hatzelmann A Church M | 1996 | Br J Pharmacol1996，118，7： | 1 |
| 18 | The preclinical pharmacology of roflumilast-a selective,oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease显示文摘 | Hatzelmann A Morcillo E J Lungarella G | 2010 | Pulm Pharmacol Ther2010，23，4： | 1 |
| 19 | The preclinical pharmacology of roflumilast-a selective,oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease显示文摘 | HATZELMANN A MORCILLO E J LUNGARELLA G | 2010 | Pulm Pharmacol Ther2010，23，4： | 1 |
| 20 | Pharmacology,clinical efficacy,and tolerability of phosphodiesterase-4 inhibitors:impact of human pharmacokinetics显示文摘 | Tenor H Hatzelmann A Beume R | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员